RBGLY changes
Pick any two versions below to diff them.
- Price
- $14.56 → $15.15(+4.1%)
- Discount category
- Well below intrinsic value → Below intrinsic value
- Recent events
- Oct 27, 2026: Reckitt reported Q3 2026 results. Core Reckitt like-for-like net revenue grew 3.3%, or 3.9% without Russia Hygiene, below the 4.2% of Q2. Emerging Markets grew 8.0% and Europe returned to growth at 0.8%. North America fell 1.3% because manufacturing limits held back Lysol supply. Mead Johnson grew 2.7%. Reckitt cut its 2026 guidance for Core Reckitt like-for-like growth to 3.5% to 4.5%, from 4% to 5%, and kept its margin guidance of 24.9% to 25.6%. It had completed £90 million of its £500 million buyback by October 23. Sep 16, 2026: Reckitt announced up to $600 million of multi-year investment in its US operations, including a new science and innovation campus in New Jersey and an expanded OTC manufacturing facility in North Carolina opening in H1 2027. removed: Sep 1, 2026: J.P. Morgan upgraded Reckitt to overweight from neutral after the Mead Johnson trial win and raised its price target to 6,500p from 5,800p. Reckitt shares rose about 4% that day. Aug 31, 2026: A federal jury in Chicago returned a unanimous defense verdict for Mead Johnson in Inman v. Mead Johnson, the first bellwether trial in the federal NEC baby-formula litigation (MDL 3026) to reach a jury verdict. The London market was closed that day, and Reckitt shares rose on September 1. Aug 20, 2026: Abbott, the other defendant in the NEC lawsuits, agreed to pay about $670 million to settle the $495 million Gill verdict and about 2,000 other NEC claims, with no admission of liability. Mead Johnson was not part of this settlement. Jul 29, 2026: Reckitt reported H1 2026 results. Core Reckitt like-for-like net revenue grew 2.7% in H1, accelerating to 4.2% in Q2. Adjusted diluted EPS fell 9.7% to 152.1p, mainly due to the Essential Home divestment. The board raised the interim dividend 5% to 88.6p and announced a new buyback of up to £500 million over the next 12 months. Full-year guidance was maintained. Jun 12, 2026: The Illinois Fifth District Appellate Court reversed a $60 million jury verdict against Mead Johnson in Watson v. Mead Johnson, an NEC case, citing errors in jury instructions on the duty to warn, and sent the case back for a new trial. Apr 9, 2026: French press reports said that Danone was studying a bid for Mead Johnson Nutrition. Neither company confirmed talks, and no sale price was confirmed. Feb 20, 2026: Reckitt paid a £1.6 billion special dividend (235 pence per share) to shareholders after the Essential Home sale. A 24-for-25 share consolidation took effect on February 2, 2026. Dec 31, 2025: Reckitt completed the sale of its Essential Home business (Air Wick, Calgon, Cillit Bang) to Advent International for up to $4.8 billion, including up to about $1.3 billion of contingent and deferred payments. Reckitt kept a 30% stake in the acquisition vehicle.